{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:21:09Z","timestamp":1790713269485,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011075","name":"UCLA Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jtocrr.2021.100242","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T08:06:58Z","timestamp":1634198818000},"page":"100242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Technical Feasibility and Safety of Repeated Computed Tomography\u2013Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-2794","authenticated-orcid":false,"given":"Puja","family":"Shahrouki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Genshaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Abtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Dubinett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Lisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherven","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Garon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2021.100242_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtocrr.2021.100242_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.21037\/tlcr.2020.03.40","article-title":"Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival","volume":"10","author":"Casal-Mouri\u00f1o","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2021.100242_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jtocrr.2021.100242_bib5","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2021.100242_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtocrr.2021.100242_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PAI.0b013e3181b6a741","article-title":"A\u00a0high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis","volume":"18","author":"Zhuang","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/PPO.0b013e3181eb33bc","article-title":"Chemokines: can effector cells be redirected to the site of the tumor?","volume":"16","author":"Dubinett","year":"2010","journal-title":"Cancer J"},{"key":"10.1016\/j.jtocrr.2021.100242_bib10","series-title":"Tumor Microenvironment Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-030-36667-4_7","article-title":"CCL21 programs immune activity in tumor microenvironment","author":"Sharma","year":"2020"},{"key":"10.1016\/j.jtocrr.2021.100242_bib11","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.molonc.2015.10.016","article-title":"In situ vaccination: cancer immunotherapy both personalized and off-the-shelf","volume":"9","author":"Hammerich","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/1078-0432.CCR-20-0473","article-title":"Intratumoral immunotherapy: from trial design to clinical practice","volume":"27","author":"Champiat","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2021.100242_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib14","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.4049\/jimmunol.164.9.4558","article-title":"Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in\u00a0vivo","volume":"164","author":"Sharma","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib15","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1158\/1078-0432.CCR-03-0380","article-title":"Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity","volume":"10","author":"Yang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2021.100242_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-4598-2-35","article-title":"Overexpression of CCL-21\/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells","volume":"2","author":"Riedl","year":"2003","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jtocrr.2021.100242_bib17","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1158\/1078-0432.CCR-16-2821","article-title":"Phase I trial of intratumoral injection of CCL21 gene-modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8+ T-cell infiltration","volume":"23","author":"Lee","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2021.100242_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1479-5876-6-38","article-title":"Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer","volume":"6","author":"Baratelli","year":"2008","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jtocrr.2021.100242_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtocrr.2021.100242_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00330-016-4357-8","article-title":"Complication rates of CT-guided transthoracic lung biopsy: meta-analysis","volume":"27","author":"Heerink","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/125.1.11","article-title":"The diagnostic accuracy and complications of closed lung biopsies","volume":"125","author":"Herman","year":"1977","journal-title":"Radiology"},{"key":"10.1016\/j.jtocrr.2021.100242_bib23","doi-asserted-by":"crossref","first-page":"20190866","DOI":"10.1259\/bjr.20190866","article-title":"Pneumothorax rates in CT-Guided lung biopsies: a comprehensive systematic review and meta-analysis of risk factors","volume":"93","author":"Huo","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2214\/ajr.171.6.9843309","article-title":"Special techniques in CT-guided transthoracic needle biopsy","volume":"171","author":"Nashed","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005382-199322000-00009","article-title":"Needle-tip localization for CT-guided biopsies","volume":"8","author":"Yankelevitz","year":"1993","journal-title":"J\u00a0Thorac Imaging"},{"key":"10.1016\/j.jtocrr.2021.100242_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0033-8389(05)70161-5","article-title":"Transthoracic needle biopsy","volume":"38","author":"Klein","year":"2000","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.jtocrr.2021.100242_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1051-0443(98)70279-9","article-title":"Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions","volume":"9","author":"Swischuk","year":"1998","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"suppl","key":"10.1016\/j.jtocrr.2021.100242_bib28","doi-asserted-by":"crossref","first-page":"S978","DOI":"10.1016\/j.jtho.2019.08.2147","article-title":"EP1.04-20 phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC","volume":"14","author":"Lisberg","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2021.100242_bib29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1164\/rccm.200803-435OC","article-title":"Association of radiographic emphysema and airflow obstruction with\u00a0lung cancer","volume":"178","author":"Wilson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtocrr.2021.100242_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00270-020-02691-3","article-title":"Treatment of post-ablation bronchopleural fistula using percutaneous synthetic hydrogel surgical sealant: initial experience of safety and efficacy","volume":"44","author":"Shahrouki","year":"2021","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364321001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364321001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:37:06Z","timestamp":1762987026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364321001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2666364321001016"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2021.100242","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technical Feasibility and Safety of Repeated Computed Tomography\u2013Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2021.100242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100242"}}